Total Payments
$1,734
2022 Payments
$265.08
Companies
17
Transactions
102
Medicare Patients
4,695
Medicare Billing
$282,246
Payment Breakdown by Category
Food & Beverage$1,312 (75.7%)
Education$421.89 (24.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,312 | 95 | 75.7% |
| Education | $421.89 | 7 | 24.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $834.62 | 38 | $0 (2022) |
| PFIZER INC. | $269.80 | 22 | $0 (2022) |
| Janssen Biotech, Inc. | $199.21 | 15 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $107.83 | 8 | $0 (2021) |
| Janssen Products, LP | $59.99 | 1 | $0 (2018) |
| Myovant Sciences Inc. | $39.14 | 3 | $0 (2022) |
| AbbVie Inc. | $38.02 | 3 | $0 (2021) |
| TOLMAR Pharmaceuticals, Inc. | $27.35 | 2 | $0 (2021) |
| Medtronic, Inc. | $26.85 | 1 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $25.37 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $265.08 | 10 | Astellas Pharma US Inc ($180.62) |
| 2021 | $310.16 | 22 | Astellas Pharma US Inc ($47.73) |
| 2020 | $135.21 | 6 | Astellas Pharma US Inc ($69.99) |
| 2019 | $206.08 | 16 | PFIZER INC. ($62.71) |
| 2018 | $359.81 | 28 | PFIZER INC. ($106.69) |
| 2017 | $457.51 | 20 | Astellas Pharma US Inc ($377.92) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Oncology | ||||||
| 02/28/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: HORMONE THERAPY | ||||||
| 02/16/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 02/16/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.00 | General |
| 02/04/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Oncology | ||||||
| 01/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Urology | ||||||
| 01/18/2022 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Analgesic| antispasmodic & antiseptic (urinary) | ||||||
| 01/12/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/13/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $12.67 | General |
| Category: Urology | ||||||
| 12/06/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2021 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Prostate Cancer | ||||||
| 12/01/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Oncology | ||||||
| 11/30/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/17/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Oncology | ||||||
| 11/11/2021 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/01/2021 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: HORMONE THERAPY | ||||||
| 09/20/2021 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/13/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Oncology | ||||||
| 08/16/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: UROLOGY | ||||||
| 08/04/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 517 | 545 | $149,366 | $17,356 |
| 2021 | 11 | 1,638 | 2,362 | $449,705 | $119,006 |
| 2020 | 15 | 2,540 | 3,899 | $265,071 | $145,884 |
Total Patients
4,695
Total Services
6,806
Medicare Billing
$282,246
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 165 | $117,150 | $13,496 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 54 | $27,054 | $3,018 | 11.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 141 | 145 | $2,175 | $434.97 | 20.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 171 | 181 | $2,987 | $407.21 | 13.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 388 | 579 | $238,710 | $61,662 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 304 | 416 | $104,169 | $30,049 | 28.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 15 | 111 | $63,690 | $14,892 | 23.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $11,290 | $5,135 | 45.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 424 | 608 | $9,120 | $1,824 | 20.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $4,964 | $1,755 | 35.3% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 15 | 39 | $3,458 | $1,136 | 32.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 353 | 463 | $7,080 | $1,042 | 14.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 36 | 36 | $3,600 | $662.04 | 18.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 46 | 52 | $2,820 | $489.09 | 17.3% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Office | 2021 | 11 | 12 | $803.50 | $360.39 | 44.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 394 | 583 | $72,875 | $48,373 | 66.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 267 | 367 | $64,225 | $44,138 | 68.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 16 | 139 | $54,571 | $24,389 | 44.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 106 | 136 | $11,560 | $7,682 | 66.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 45 | 119 | $7,140 | $4,669 | 65.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 562 | 854 | $12,810 | $4,401 | 34.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 462 | 668 | $6,680 | $1,978 | 29.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 562 | 854 | $8,540 | $1,910 | 22.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $3,750 | $1,846 | 49.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 15 | $3,750 | $1,792 | 47.8% |
About Dr. Jack Ebani, MD
Dr. Jack Ebani, MD is a Urology healthcare provider based in Neptune, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962563932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Ebani, MD has received a total of $1,734 in payments from pharmaceutical and medical device companies, with $265.08 received in 2022. These payments were reported across 102 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,312).
As a Medicare-enrolled provider, Ebani has provided services to 4,695 Medicare beneficiaries, totaling 6,806 services with total Medicare billing of $282,246. Data is available for 3 years (2020–2022), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Neptune, NJ
- Active Since 12/13/2006
- Last Updated 03/17/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1962563932
Products in Payments
- XTANDI (Drug) $380.52
- Myrbetriq (Drug) $199.80
- ZYTIGA (Drug) $126.43
- Erleada (Drug) $109.08
- Xtandi (Drug) $93.76
- Nubeqa (Drug) $68.76
- MYRBETRIQ (Drug) $61.85
- ORGOVYX (Drug) $39.14
- Xofigo (Drug) $39.07
- LUPRON DEPOT (Drug) $38.02
- ERLEADA (Drug) $36.76
- ELIGARD (Drug) $27.35
- INTERSTIM (Device) $26.85
- PROVENGE (Drug) $25.37
- REZUM (Device) $22.89
- TOVIAZ (Drug) $21.70
- Uribel (Drug) $16.19
- Noctiva (Drug) $15.01
- KEYTRUDA (Biological) $14.60
- GEMTESA (Drug) $12.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.